NervoLyn Was Built Behind a Pharmacy Counter

The complaint that started it

Marion Rockvale filled prescriptions for thirty one years. The conversation that repeated itself was never about a prescription: it was the customer leaning in at the end to say their feet buzzed at night, or their hands went cold and stayed cold, and to ask whether the magnesium on the shelf behind him was worth buying.

His honest answer was usually half a yes. Magnesium mattered, the cheap oxide tablets sat badly with a lot of people, and none of it addressed circulation. So in 2017 he wrote down what he would have wanted to hand across the counter: a chelated magnesium at a daily dose people could tolerate, with a small set of supporting actives around it, in one capsule a day so nobody had to remember a schedule.

That became NervoLyn. The company he founded still carries his family name, and the formula has not been thinned out since.

Why we sell it direct

A retail shelf adds two things: a margin and a stranger between us and the person taking the capsule. Selling NervoLyn ourselves means the price ladder is ours to set, the stock on hand is dated by us, and the refund desk reports to the same company that approved the label. When a buyer writes to complain, it lands on our desk, not a retailer’s help queue.

It also means we can say something most brands cannot: if you find NervoLyn on a marketplace, we did not put it there. We have no record of how that bottle travelled, and our promise does not reach it.

Our quality standards

Every raw material arrives with a certificate of analysis. Finished batches are checked for identity, potency, heavy metals and microbial safety before release, in an FDA registered facility working to cGMP standards. We publish the standard rather than dressing it up with numbers that would mean nothing out of context.